Clinical Trials Browser

Phase 2 × Glucose × Clear all

NCT02253316 2025-11-10

Phase II Study of IRD (Ixazomib, Lenalidomide, Dexamethasone) Post Autologous Stem Cell Transplantation Followed by Maintenance Ixazomib or Lenalidomide for Multiple Myeloma

Phase 2 Active not recruiting

236 enrolled 13 charts

Multiple Myeloma

NCT06855628 2025-10-28

Assessment of Novel Metabolic Imaging Modalities as A Predictor Of Therapeutic EfficacyiIn Glioblastoma (GBM)

Phase 2 Suspended

Glioma

NCT00597909 2024-12-17

Efficacy and Safety Study of Ammonul® in Patients With Grade 3 or 4 Hepatic Encephalopathy

Phase 2 Terminated

Hepatic Encephalopathy, Lymphoma, Follicular

NCT04782856 2024-06-14

Energy Metabolism in Thyroidectomized Patients

Phase 2 Completed

13 enrolled 10 charts

Goiter, Hypothyroidism, Thyroid Neoplasms

NCT04863248 2023-04-14

PRESERVE 4

Phase 2 Terminated

10 enrolled 14 charts

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm Metastasis

NCT02012608 2019-05-29

Glutamine for the Prevention of Radiation Toxicity in Subjects Conserving Therapy

Phase 2 Terminated

14 enrolled 5 charts

Breast Neoplasms